Determination of whether TLR4 signaling can be activated in the heart by insulin may shed light on the pathogenesis of diabetic cardiomyopathy, a process that is often complicated by obesity and insulin resistance. This evidence concerns the gene TLR4 and obesity due to melanocortin 4 receptor deficiency.